BioTime, Inc. has announced that its subsidiary company, LifeMap Sciences, has created a medical technology startup of its own called LifeMap Solutions, Inc.
LifeMap Solutions was brought about to focus on creating innovative mobile health products and services that benefit both doctors and patients through the use of big data. The company’s first project is expected to be an app that provides information based on the interpretations of multiple components of clinical data, along with the health information from other individuals relating to human disease, health and overall wellness.
To create these products, LifeMap Solutions plans to team up with the Icahn School of Medicine at Mount Sinai Hospital. The company is still quite secretive about the exact nature of what their products will be, but LifeMap Solutions was willing to disclose that their planned products will be interactive mobile apps that connect users to their own complex personal health information, with personalized advice based on the correlations found between their health records and big data findings. Mount Sinai's role in the project is to provide a developmental software engine to LifeMap Solutions, which will be responsible for everything else for the technology platform, including the necessary server and client components.
BioTime, a leading biotechnology company that does research and development in the field of regenerative medicine, is planning to foot the bill for the initial financing of LifeMap Solutions, and Mount Sinai is also expected to defray a portion of the development costs of the project by offering their personnel and services at reduced costs. According to BioTime CEO Dr. Michael West, “The creation of LifeMap Solutions represents a strategic step along BioTime's path toward extending LifeMap's leadership in online genomic and medical information.”
Ultimately, he hopes that their products will help to “markedly enhance the public's access to big data and to improve quality of life.”
Edited by
Rory J. Thompson
